Crossmark

Investigation of the effect of encapsulating cisplatin with the active compound silibinin in PLGA polymeric nanoparticles on the HeLa cervical cancer cell line

Crossref DOI link: https://doi.org/10.1007/s12032-025-03200-7

Published Online: 2025-12-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Akbari, Parinaz

Ali, Hameed A.

Negahi, Mohammad

Frimayanti, Neni

Yaeghoobi, Marzieh

Taebpour, Mohammad

Haghiralsadat, Bibi Fatemeh

Razmjoue, Damoun

Oroojalian, Fatemeh
Funding

Funding for this research was provided by:

NanoBiotechnologists Fardanegar Co. Yazd Science and Technology Park, Yazd, Iran
License Information

Text and Data Mining valid from 2025-12-26

Version of Record valid from 2025-12-26
More Information

Article History

Received: 27 July 2025

Accepted: 5 December 2025

First Online: 26 December 2025

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below